申请人:Katayama Seiji
公开号:US20130116227A1
公开(公告)日:2013-05-09
Disclosed is a novel biaryl amide derivative represented by formula (1) and having an affinity for the aldosterone receptor; also disclosed is a pharmaceutically acceptable salt thereof. (In the formula, A is any of the groups represented by formula (a); L is —CONH—, etc.; R
1
is a substitutable aminosulfonyl group, etc.; R
2
is a hydrogen atom, etc.; R
3
is a hydrogen atom, etc.; R
4
is a hydrogen atom, a halogen atom, hydroxy group, a substitutable amino group, a substitutable C
1-6
alkoxy group, a substitutable 4- to 7-membered cyclic amino group, etc.; R
5a
, R
5b
and R
5c
are each independently hydrogen atoms, etc.; R
6
is a halogen atom, a cyano group, etc.; R
7
and R
8
are each independently a hydrogen atom, etc.; and m is an integer such as 0.)
揭示了一种表示为公式(1)的新型联苯酰胺衍生物,具有与醛固酮受体的亲和力;还揭示了其药用可接受的盐。(在该公式中,A是由公式(a)表示的任何基团之一;L是—CONH—等;R1是可替代的氨基磺酰基等;R2是氢原子等;R3是氢原子等;R4是氢原子、卤原子、羟基、可替代的氨基基团、可替代的C1-6烷氧基、可替代的4-到7-成员环氨基基团等;R5a、R5b和R5c各自独立地是氢原子等;R6是卤原子、氰基等;R7和R8各自独立地是氢原子等;m是整数,例如0。)